Novel paradigms for dialysis vascular access: Downstream vascular biology-is there a final common pathway?

Clinical Journal of the American Society of Nephrology

Volumn 8, Issue 12, 2013, Pages 2194-2201

  Lee, Timmy ^a,b,c,d  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c Dialysis Vascular Access Research Group   (United States)

^d University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; ELASTIN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GELATINASE A; GELATINASE B; GELFOAM; HEME OXYGENASE 1; INDUCIBLE NITRIC OXIDE SYNTHASE; MONOCYTE CHEMOTACTIC PROTEIN 1; N (G), N (G) DIMETHYLARGININE; NITRIC OXIDE; PACLITAXEL; PEROXYNITRITE; SUPEROXIDE; TEMPOL; UNCLASSIFIED DRUG;

ARTERIOVENOUS FISTULA; ARTERIOVENOUS GRAFT; ARTICLE; BALLOON; BLOOD VESSEL GRAFT; CELL MIGRATION; DRUG COATED BALLOON; DRUG ELUTING STENT; ENDOTHELIAL DYSFUNCTION; ENDOVASCULAR SURGERY; GENOMICS; HEMODIALYSIS; HUMAN; HYPERPLASIA; HYPERTHERMIC THERAPY; MULTICENTER STUDY (TOPIC); NEOINTIMA; NONHUMAN; OXIDATIVE STRESS; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PHASE 2 CLINICAL TRIAL (TOPIC); RANDOMIZED CONTROLLED TRIAL (TOPIC); STENOSIS; UREMIA; VASCULAR ACCESS; VASCULAR ACCESS DYSFUNCTION; VASCULAR BIOLOGY; VASCULAR DISEASE; ANIMAL; ARTERIOVENOUS SHUNT; BLOOD FLOW; GRAFT OCCLUSION, VASCULAR; PATHOLOGY; PATHOPHYSIOLOGY; RENAL REPLACEMENT THERAPY; RISK FACTOR; STENOSIS, OCCLUSION AND OBSTRUCTION; TREATMENT OUTCOME; VASCULAR PATENCY; VASCULAR SYSTEM INJURIES;

ANIMALS; ARTERIOVENOUS SHUNT, SURGICAL; CONSTRICTION, PATHOLOGIC; ENDOVASCULAR PROCEDURES; GRAFT OCCLUSION, VASCULAR; HUMANS; HYPERPLASIA; NEOINTIMA; REGIONAL BLOOD FLOW; RENAL DIALYSIS; RISK FACTORS; TREATMENT OUTCOME; VASCULAR PATENCY; VASCULAR SYSTEM INJURIES;

EID: 84889811459     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.03490413     Document Type: Article

References (68)

1. Collins AJ, Foley RN, Herzog C, Chavers B, Gilbertson D, Ishani A, Kasiske B, Liu J, Mau LW, McBean M, Murray A, St. Peter W, Guo H, Gustafson S, Li Q, Li S, Li S, Peng Y, Qiu Y, Roberts T, Skeans M, Snyder J, Solid C, Wang C, Weinhandl E, Zaun D, Arko C, Chen SC, Dalleska F, Daniels F, Dunning S, Ebben J, Frazier E, Hanzlik C, Johnson R, Sheets D, Wang X, Forrest B, Constantini E, Everson S, Eggers P, Agodoa L: US Renal Data System2010 Annual Data Report. Am J Kidney Dis 57[Suppl 1]: A8, e1-e526, 2011
2. Feldman HI, Joffe M, Rosas SE, Burns JE, Knauss J, Brayman K: Predictors of successful arteriovenous fistula maturation. Am J Kidney Dis 42: 1000-1012, 2003
3. Feldman HI, Kobrin S, Wasserstein A: Hemodialysis vascular access morbidity. J Am Soc Nephrol 7: 523-535, 1996
4. Dhingra RK, Young EW, Hulbert-Shearon TE, Leavey SF, Port FK: Type of vascular access and mortality in U.S. hemodialysis patients. Kidney Int 60: 1443-1451, 2001
5. Dember LM, Beck GJ, Allon M, Delmez JA, Dixon BS, Greenberg A, Himmelfarb J, Vazquez MA, Gassman JJ, Greene T, Radeva MK, Braden GL, Ikizler TA, Rocco MV, Davidson IJ, Kaufman JS, Meyers CM, Kusek JW, Feldman HI; Dialysis Access Consortium Study Group: Effect of clopidogrel on early failure of arteriovenous fistulas for hemodialysis: A randomized controlled trial. JAMA 299: 2164-2171, 2008
6. Roy-Chaudhury P, Arend L, Zhang J, Krishnamoorthy M, Wang Y, Banerjee R, Samaha A, Munda R: Neointimal hyperplasia in early arteriovenous fistula failure. Am J Kidney Dis 50: 782-790, 2007
7. Rothuizen TC, Wong C, Quax PH, van Zonneveld AJ, Rabelink TJ, Rotmans JI: Arteriovenous access failure: more than just intimal hyperplasia? Nephrol Dial Transplant 28: 1085-1092, 2013
8. Lee T, Roy-Chaudhury P: Advances and new frontiers in the pathophysiology of venous neointimal hyperplasia and dialysis access stenosis. Adv Chronic Kidney Dis 16: 329-338, 2009
9. Dixon BS:Why don't fistulas mature? Kidney Int 70: 1413-1422, 2006
10. Asif A, Roy-Chaudhury P, Beathard GA: Early arteriovenous fistula failure: A logical proposal for when and how to intervene. Clin J Am Soc Nephrol 1: 332-339, 2006
11. Beathard GA: Angioplasty for arteriovenous grafts and fistulae. Semin Nephrol 22: 202-210, 2002
12. Roy-Chaudhury P, Kelly BS, Miller MA, Reaves A, Armstrong J, Nanayakkara N, Heffelfinger SC: Venous neointimal hyperplasia in polytetrafluoroethylene dialysis grafts. Kidney Int 59: 2325-2334, 2001
13. Chang CJ, Ko PJ, Hsu LA, Ko YS, Ko YL, Chen CF, Huang CC, Hsu TS, Lee YS, Pang JH: Highly increased cell proliferation activity in the restenotic hemodialysis vascular access after percutaneous transluminal angioplasty: Implication in prevention of restenosis. Am J Kidney Dis 43: 74-84, 2004
14. Shi Y, O'Brien JE, Fard A, Mannion JD, Wang D, Zalewski A: Adventitial myofibroblasts contribute to neointimal formation in injured porcine coronary arteries. Circulation 94: 1655-1664, 1996
15. Shi Y, O'Brien JE Jr, Ala-Kokko L, Chung W, Mannion JD, Zalewski A: Origin of extracellular matrix synthesis during coronary repair. Circulation 95: 997-1006, 1997
16. Wasse H, Huang R, Naqvi N, Wang D, Husain A: Inflammation, oxidation and venous neointimal hyperplasia precede vascular injury from AVF creation in CKD patients. J Vasc Access 13: 168-174, 2012
17. Wasse H, Rivera AA, Huang R, Martinson DE, Long Q, McKinnon W, Naqvi N, Husain A: Increased plasma chymase concentration and mast cell chymase expression in venous neointimal lesions of patients with CKD and ESRD. Semin Dial 24: 688-693, 2011
18. Lee T, Chauhan V, Krishnamoorthy M, Wang Y, Arend L, Mistry MJ, El-Khatib M, Banerjee R, Munda R, Roy-Chaudhury P: Severe venous neointimal hyperplasia prior to dialysis access surgery. Nephrol Dial Transplant 26: 2264-2270, 2011
19. Alpers CE: Prominent neointimal hyperplasia is common in veins utilized for AV fistula creation: the Hemodialysis Maturation (HFM) study [Abstract]. J Am Soc Nephrol 23: 14A, 2012
20. Allon M, Litovsky S, Young CJ, Deierhoi MH, Goodman J, Hanaway M, Lockhart ME, Robbin ML: Medial fibrosis, vascular calcification, intimal hyperplasia, and arteriovenous fistula maturation. Am J Kidney Dis 58: 437-443, 2011
21. Beathard GA, Arnold P, Jackson J, Litchfield T; Physician Operators Forum of RMS Lifeline: Aggressive treatment of early fistula failure. Kidney Int 64: 1487-1494, 2003
22. Kim YO, Song HC, Yoon SA, Yang CW, Kim NI, Choi YJ, Lee EJ, Kim WY, Chang YS, Bang BK: Preexisting intimal hyperplasia of radial artery is associated with early failure of radiocephalic arteriovenous fistula in hemodialysis patients. Am J Kidney Dis 41: 422-428, 2003
23. Kim HG, Park SC, Lee SL, Shin OR, Yoon SA, Yang CW, Kim Y, Kim YO: Arterial micro-calcification of vascular access is associated with aortic arch calcification and arterial stiffness in hemodialysis patients. Semin Dial 26: 216-222, 2013
24. Roy-Chaudhury P, Sukhatme VP, Cheung AK: Hemodialysis vascular access dysfunction: A cellular andmolecular viewpoint. J Am Soc Nephrol 17: 1112-1127, 2006
25. Lin CC, Yang WC, Lin SJ, Chen TW, Lee WS, Chang CF, Lee PC, Lee SD, Su TS, Fann CS, Chung MY: Length polymorphism in heme oxygenase-1 is associated with arteriovenous fistula patency in hemodialysis patients. Kidney Int 69: 165-172, 2006
26. Juncos JP, Tracz MJ, Croatt AJ, Grande JP, Ackerman AW, Katusic ZS, Nath KA: Genetic deficiency of heme oxygenase-1 impairs functionality and form of an arteriovenous fistula in the mouse. Kidney Int 74: 47-51, 2008
27. Castier Y, Brandes RP, Leseche G, Tedgui A, Lehoux S: p47phoxdependent NADPH oxidase regulates flow-induced vascular remodeling. Circ Res 97: 533-540, 2005
28. Tronc F, Mallat Z, Lehoux S, Wassef M, Esposito B, Tedgui A: Role of matrix metalloproteinases in blood flow-induced arterial enlargement: Interaction with NO. Arterioscler Thromb Vasc Biol 20: E120-E126, 2000
29. Zempo N, Koyama N, Kenagy RD, Lea HJ, Clowes AW: Regulation of vascular smooth muscle cell migration and proliferation in vitro and in injured rat arteries by a synthetic matrix metalloproteinase inhibitor. Arterioscler Thromb Vasc Biol 16: 28-33, 1996
30. Bendeck MP, Zempo N, Clowes AW, Galardy RE, Reidy MA: Smooth muscle cell migration and matrix metalloproteinase expression after arterial injury in the rat. Circ Res 75: 539-545, 1994
31. Tsapenko MV, d'Uscio LV, Grande JP, Croatt AJ, Hernandez MC, Ackerman AW, Katusic ZS, Nath KA: Increased production of superoxide anion contributes to dysfunction of the arteriovenous fistula. Am J Physiol Renal Physiol 303: F1601-F1607, 2012
32. Juncos JP, Grande JP, Kang L, Ackerman AW, Croatt AJ, Katusic ZS, Nath KA: MCP-1 contributes to arteriovenous fistula failure. J Am Soc Nephrol 22: 43-48, 2011
33. Daly C, Rollins BJ: Monocyte chemoattractant protein-1 (CCL2) in inflammatory disease and adaptive immunity: Therapeutic opportunities and controversies. Microcirculation 10: 247-257, 2003
34. Charo IF, Ransohoff RM: The many roles of chemokines and chemokine receptors in inflammation. N Engl J Med 354: 610-621, 2006
35. Deshmane SL, Kremlev S, Amini S, Sawaya BE: Monocyte chemoattractant protein-1 (MCP-1): An overview. J Interferon Cytokine Res 29: 313-326, 2009
36. Schober A: Chemokines in vascular dysfunction and remodeling. Arterioscler Thromb Vasc Biol 28: 1950-1959, 2008
37. Schepers A, Eefting D, Bonta PI, Grimbergen JM, de Vries MR, van Weel V, de Vries CJ, Egashira K, van Bockel JH, Quax PH: Anti-MCP-1 gene therapy inhibits vascular smooth muscle cells proliferation and attenuates vein graft thickening both in vitro and in vivo. Arterioscler Thromb Vasc Biol 26: 2063-2069, 2006
38. Owens CD, Wake N, Kim JM, Hentschel D, Conte MS, Schanzer A: Endothelial function predicts positive arterial-venous fistula remodeling in subjects with stage IV and V chronic kidney disease. J Vasc Access 11: 329-334, 2010
39. Croatt AJ, Grande JP, Hernandez MC, Ackerman AW, Katusic ZS, Nath KA: Characterization of a model of an arteriovenous fistula in the rat: The effect of L-NAME. Am J Pathol 176: 2530-2541, 2010
40. Wu CC, Wen SC, Yang CW, Pu SY, Tsai KC, Chen JW: Plasma ADMA predicts restenosis of arteriovenous fistula. J Am Soc Nephrol 20: 213-222, 2009
41. Schwartz SM, deBlois D, O'Brien ER: The intima. Soil for atherosclerosis and restenosis. Circ Res 77: 445-465, 1995
42. Raines EW, Ross R: Smooth muscle cells and the pathogenesis of the lesions of atherosclerosis. Br Heart J 69[Suppl]: S30-S37, 1993
43. Austin GE, Ratliff NB, Hollman J, Tabei S, Phillips DF: Intimal proliferation of smooth muscle cells as an explanation for recurrent coronary artery stenosis after percutaneous transluminal coronary angioplasty. J Am Coll Cardiol 6: 369-375, 1985
44. Shi Y, O'Brien JE Jr, Mannion JD, Morrison RC, Chung W, Fard A, Zalewski A: Remodeling of autologous saphenous vein grafts. The role of perivascularmyofibroblasts. Circulation 95: 2684-2693, 1997
45. Shi ZD, Tarbell JM: Fluid flow mechanotransduction in vascular smooth muscle cells and fibroblasts. Ann Biomed Eng 39: 1608-1619, 2011
46. Sartore S, Chiavegato A, Faggin E, Franch R, Puato M, Ausoni S, Pauletto P: Contribution of adventitial fibroblasts to neointima formation and vascular remodeling: From innocent bystander to active participant. Circ Res 89: 1111-1121, 2001
47. Li L, Terry CM, Blumenthal DK, Kuji T, Masaki T, Kwan BC, Zhuplatov I, Leypoldt JK, Cheung AK: Cellular and morphological changes during neointimal hyperplasia development in a porcine arteriovenous graft model. Nephrol Dial Transplant 22: 3139-3146, 2007
48. Misra S, Doherty MG, Woodrum D, Homburger J, Mandrekar JN, Elkouri S, Sabater EA, Bjarnason H, Fu AA, Glockner JF, Greene EL, Mukhopadhyay D: Adventitial remodeling with increased matrix metalloproteinase-2 activity in a porcine arteriovenous polytetrafluoroethylene grafts. Kidney Int 68: 2890-2900, 2005
49. Diao Y, Guthrie S, Xia SL, Ouyang X, Zhang L, Xue J, Lee P, Grant M, Scott E, Segal MS: Long-term engraftment of bone marrowderived cells in the intimal hyperplasia lesion of autologous vein grafts. Am J Pathol 172: 839-848, 2008
50. Peden EK, Leeser DB, Dixon BS, El-Khatib MT, Roy-Chaudhury P, Lawson JH, Menard MT, Dember LM, Glickman MH, Gustafson PN, Blair AT, Magill M, Franano FN, Burke SKA multi-center, dose-escalation study of human type I pancreatic elastase (PRT-201) administered after arteriovenous fistula creation. J Vasc Access 14: 143-151, 2013
51. Conte MS, Nugent HM, Gaccione P, Guleria I, Roy-Chaudhury P, Lawson JH: Multicenter phase I/II trial of the safety of allogeneic endothelial cell implants after the creation of arteriovenous access for hemodialysis use: The V-HEALTH study. J Vasc Surg 50: 1359-1368, e1351, 2009
52. Beathard GA: Percutaneous transvenous angioplasty in the treatment of vascular access stenosis. Kidney Int 42: 1390-1397, 1992
53. Beathard GA: Fistula salvage by endovascular therapy. Adv Chronic Kidney Dis 16: 339-351, 2009
54. Beathard GA, Settle SM, Shields MW: Salvage of the nonfunctioning arteriovenous fistula. Am J Kidney Dis 33: 910-916, 1999
55. Malik N, Francis SE, Holt CM, Gunn J, Thomas GL, Shepherd L, Chamberlain J, Newman CM, Cumberland DC, Crossman DC: Apoptosis and cell proliferation after porcine coronary angioplasty. Circulation 98: 1657-1665, 1998
56. Rotmans JI, Pattynama PM, Verhagen HJ, Hino I, Velema E, Pasterkamp G, Stroes ES: Sirolimus-eluting stents to abolish intimal hyperplasia and improve flow in porcine arteriovenous grafts: A 4-week follow-up study. Circulation 111: 1537-1542, 2005
57. Tay K, Irani J, Lo R, Taneja M, Teo T, Khoo L, Burgmans M, Yang W, Choong L, Tan S, Chng S, Pasupathy S, Tan B: Prospective randomised controlled trial comparing drug eluting stent (DES) versus percutaneous transluminal angioplasty (PTA) for the treatment of hemodialysis arterio-venous graft (AVG) stenoses: Preliminary report [Abstract]. J Vasc Interv Radiol 22: S6, 2011
58. Katsanos K, Karnabatidis D, Kitrou P, Spiliopoulos S, Christeas N, Siablis D: Paclitaxel-coated balloon angioplasty vs. plain balloon dilation for the treatment of failing dialysis access: 6-month interim results from a prospective randomized controlled trial. J Endovasc Ther 19: 263-272, 2012
59. Lin CC, Chang CF, Lai MY, Chen TW, Lee PC, Yang WC: Farinfrared therapy: a novel treatment to improve access blood flow and unassisted patency of arteriovenous fistula in hemodialysis patients. J Am Soc Nephrol 18: 985-992, 2007
60. Lin CC, Liu XM, Peyton K, Wang H, Yang WC, Lin SJ, Durante W: Far infrared therapy inhibits vascular endothelial inflammation via the induction of heme oxygenase-1. Arterioscler Thromb Vasc Biol 28: 739-745, 2008
61. Lin CC, Yang WC, Chen MC, Liu WS, Yang CY, Lee PC: Effect of far Infrared therapy on arteriovenous fistula maturation: An open-label randomized controlled trial. Am J Kidney Dis 62: 304-311, 2013
62. Misra S, Fu AA, Anderson JL, Sethi S, Glockner JF, McKusick MA, Bjarnason H, Woodrum DA, Mukhopadhyay D: The rat femoral arteriovenous fistula model: Increased expression of matrix metalloproteinase-2 and-9 at the venous stenosis. J Vasc Interv Radiol 19: 587-594, 2008
63. Castier Y, Lehoux S, Hu Y, Foteinos G, Tedgui A, Xu Q: Characterization of neointima lesions associated with arteriovenous fistulas in a mouse model. Kidney Int 70: 315-320, 2006
64. Kelly BS, Heffelfinger SC, Whiting JF, Miller MA, Reaves A, Armstrong J, Narayana A, Roy-Chaudhury P: Aggressive venous neointimal hyperplasia in a pig model of arteriovenous graft stenosis. Kidney Int 62: 2272-2280, 2002
65. Misra S, Woodrum DA, Homburger J, Elkouri S, Mandrekar JN, Barocas V, Glockner JF, Rajan DK, Mukhopadhyay D: Assessment of wall shear stress changes in arteries and veins of arteriovenous polytetrafluoroethylene grafts using magnetic resonance imaging. Cardiovasc Intervent Radiol 29: 624-629, 2006
66. Misra S, Fu AA, Anderson JL, Glockner JF, McKusick MA, Bjarnason H, Woodrum DA, Mukhopadhyay D: Fetuin-A expression in early venous stenosis formation in a porcinemodel of hemodialysis graft failure. J Vasc Interv Radiol 19: 1477-1482, 2008
67. Kokubo T, Ishikawa N, Uchida H, Chasnoff SE, Xie X, Mathew S, Hruska KA, Choi ET: CKD accelerates development of neointimal hyperplasia in arteriovenous fistulas. J Am Soc Nephrol 20: 1236-1245, 2009
68. Verschuren JJ, Ocak G, Dekker FW, Rabelink TJ, Jukema JW, Rotmans JI: Candidate gene analysis of arteriovenous fistula failure in hemodialysis patients [published online ahead of print April 4, 2013]. J Am Soc Nephrol doi: 10.2215/CJN.11091012